|
|
Volumn 19, Issue 8, 1996, Pages 896-898
|
|
Should we use intensive insulin therapy after oral agent failure in type II diabetes?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
ALBUMINURIA;
ARTICLE;
DIABETIC ANGIOPATHY;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
HUMAN;
MORBIDITY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
RISK FACTOR;
TREATMENT FAILURE;
ADMINISTRATION, ORAL;
ALBUMINURIA;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DIABETIC NEUROPATHIES;
DIABETIC RETINOPATHY;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MORBIDITY;
RISK FACTORS;
TREATMENT FAILURE;
|
|
EID: 0030207264
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.19.8.896 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
